Meeting
2022 ASCO Genitourinary Cancers Symposium
Hereditary cancer risk assessment in the community urology practice setting.
Authors
Neal D. Shore
Urology, Carolina Urologic Research Center and Atlantic Urology Clinics, Myrtle Beach, SC
Neal D. Shore , Lauren Lenz , Darl D. Flake II, Stephanie Meek , Thaylon Davis , Karen Copeland , Rob Finch , William Schiff , Howard Korman , Manoj Rao , Laurence Belkoff , Richard D'Anna , Thomas Slavin , Todd Cohen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Clinical Trial Registration Number
NCT04015102
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 278)
DOI
10.1200/JCO.2022.40.6_suppl.278
Abstract #
278
Poster Bd #
N7
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Inherited risk for prostate cancer (PCa): Following the natural history of men with high-risk genetics using multiparametric MRI (mpMRI).
First Author: Anna Couvillon
Poster
2023 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2022 ASCO Genitourinary Cancers Symposium
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
First Author: Channing Judith Paller
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian